Written by: Dr. Albana Greca Sejdini, MD, MMedSc
Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist
Last medically reviewed: July 2026
Insulin resistance treatment is not one pill, one diet, or one laboratory target. The goal is to improve how muscle, liver, and fat tissue respond to insulin, reduce progression to type 2 diabetes when possible, and treat the associated risks—such as high blood pressure, abnormal cholesterol, metabolic liver disease, sleep apnea, and excess abdominal fat.
Insulin resistance means that the body needs more insulin than usual to produce the same metabolic effect. The pancreas may initially compensate by producing more insulin, allowing glucose to remain normal. Prediabetes or type 2 diabetes develops when this compensation is no longer sufficient.
Treatment may aim to:
Not everyone with insulin resistance will develop type 2 diabetes, and not everyone will return every laboratory marker to a textbook range. Meaningful improvement can include better glucose, lower waist measurement, improved fitness, lower triglycerides, reduced liver fat, better sleep, or reduced medicine requirements.
Insulin resistance often has no symptoms. Fatigue, hunger, difficulty losing weight, darkened skin folds, irregular periods, or abdominal weight gain may occur, but none of these proves the diagnosis.
A clinical assessment may include:
Fasting insulin and HOMA-IR can support an assessment in selected settings, but they are not standardized well enough to serve as universal stand-alone diagnostic tests. The euglycemic clamp is a research reference method and is rarely needed in routine care.
Read Insulin Resistance Tests: What Laboratory Results Can Show and Blood Tests for Diabetes.
Active muscle can take up more glucose during and after exercise. This benefit can occur even before substantial weight loss and may continue for hours after activity.
For many adults, a practical goal is:
Activity can be divided into shorter sessions. A ten- or fifteen-minute walk after meals may be easier to maintain than one long workout and may reduce the after-meal glucose rise for some people.
If you are inactive, begin gradually. Five to ten minutes may be a meaningful starting point. Increase duration, frequency, or intensity one step at a time.
Ask for medical guidance before beginning vigorous exercise when you have:
Exercise should be adapted—not abandoned—when joint pain, disability, neuropathy, or reduced fitness is present. Seated resistance exercise, water-based activity, recumbent cycling, and supervised rehabilitation may be alternatives.
Excess visceral fat and fat stored in the liver and muscles can contribute to insulin resistance. For adults with overweight or obesity and prediabetes, losing approximately 5–7% of starting weight can meaningfully reduce progression to type 2 diabetes.
For a person weighing:
| Starting weight | 5% loss | 7% loss |
|---|---|---|
| 70 kg / 154 lb | 3.5 kg / 8 lb | 4.9 kg / 11 lb |
| 90 kg / 198 lb | 4.5 kg / 10 lb | 6.3 kg / 14 lb |
| 110 kg / 243 lb | 5.5 kg / 12 lb | 7.7 kg / 17 lb |
This is a risk-reduction target, not a requirement for every patient. People at a lower body weight can still have insulin resistance because of genetics, visceral-fat distribution, lipodystrophy, PCOS, medicines, sleep apnea, liver disease, or other factors. They should not be told to lose weight automatically.
Weight management may include:
Weight regain is common because obesity is a chronic biological disease. Continued support is more appropriate than blame.
| DPP group | Main intervention | Reduction in diabetes progression over about 3 years |
|---|---|---|
| Intensive lifestyle | Goal of 7% weight loss and 150 minutes of activity weekly | 58% compared with placebo |
| Metformin | 850 mg twice daily in the clinical trial plus standard lifestyle advice | 31% compared with placebo |
The DPP results describe a structured intervention in high-risk research participants. They do not mean that every person will achieve the same result or that the clinical-trial metformin dose should be copied without a prescription.
The old advice to reduce high-GI carbohydrates was partly useful but incomplete. Reducing refined carbohydrate and sugary drinks may lower glucose and calorie intake, but insulin is still needed to regulate glucose from food and from the liver. The goal is not to create “no need for insulin secretion.”
A practical eating pattern emphasizes:
There is no single best macronutrient percentage. Mediterranean-style, lower-carbohydrate, DASH-style, vegetarian, or other patterns can work when they are nutritionally adequate, sustainable, and matched to the person’s medicines and health conditions.
Low glycemic index does not mean low carbohydrate or unlimited. Portion size and total carbohydrate often matter more than the GI category alone.
Read Diet for Insulin Resistance: Foods and Meal Plan, Diabetic Meal Plan and Plate Method, and Diabetes, Carbohydrates, and Glycemic Index.
Short sleep, irregular sleep schedules, and obstructive sleep apnea can worsen insulin sensitivity, appetite regulation, blood pressure, and glucose. Seek assessment for loud snoring, witnessed breathing pauses, morning headaches, or marked daytime sleepiness.
Stress hormones may raise glucose and make sleep, eating, and activity harder. Yoga, breathing exercises, counseling, social support, and mindfulness may help some people, but yoga is not a substitute for glucose testing or indicated medicine.
Smoking increases cardiovascular risk and is associated with metabolic harm. Stopping smoking or vaping is an important part of risk reduction. Support may include counseling and approved cessation medicines.
Alcohol adds calories, may raise triglycerides, disrupt sleep, and interact with medicines. It should not be used to lower glucose. People who do not drink should not start for metabolic benefit.
Improvement may require treatment beyond food and exercise.
| Contributing factor | Possible management approach |
|---|---|
| Sleep apnea | Sleep study, positive-airway-pressure treatment, weight management, and sleep-hygiene support. |
| PCOS | Nutrition, activity, weight management when appropriate, cycle and fertility treatment, and metformin for selected indications. |
| Metabolic liver disease | Weight management, diabetes treatment, alcohol review, cardiovascular-risk treatment, and liver fibrosis assessment. |
| Corticosteroid therapy | Use the lowest medically appropriate dose, monitor glucose at the correct times, and treat steroid-related hyperglycemia when needed. |
| Antipsychotic or other weight-promoting medicine | Do not stop abruptly; review alternatives, metabolic monitoring, and preventive treatment with the prescriber. |
| Hypothyroidism or endocrine disease | Confirm the diagnosis and treat the underlying hormone disorder. |
| Lipodystrophy or severe genetic insulin resistance | Specialist evaluation and condition-specific treatment. |
Do not stop corticosteroids, psychiatric medicines, hormone treatment, or another essential medicine without the prescribing clinician.
Metformin reduces excessive liver glucose production and improves glucose regulation. It is approved to treat type 2 diabetes. In the United States, it is also commonly used off-label to help delay type 2 diabetes in selected high-risk adults with prediabetes.
ADA 2026 advises considering metformin particularly in adults at high risk, especially those who have one or more of the following:
These factors guide a discussion; they are not an automatic prescription checklist.
Common adverse effects include nausea, diarrhea, abdominal discomfort, and reduced appetite. Starting with a low dose, increasing gradually, taking it with food, or using an extended-release product may improve tolerance when the prescriber agrees.
Long-term metformin can contribute to vitamin B12 deficiency, so periodic assessment should be considered—especially with anemia, neuropathy, vegan eating, malabsorption, or prolonged high-dose use.
Kidney function should be reviewed. Metformin may need to be held during severe dehydration, serious illness, surgery, or certain contrast-imaging situations according to medical instructions.
Read Metformin and Insulin Resistance and Diabetes Medicines: Benefits and Side Effects.
The original page stated that other medicines are not recommended because they have severe side effects. That is too broad. The correct choice depends on what condition is being treated.
Metformin has the strongest long-term evidence and safety experience for diabetes prevention. No medicine should be prescribed solely from a fasting-insulin value. Other glucose-lowering drugs have shown diabetes-delay effects in trials, but cost, adverse effects, weight regain after stopping, and limited long-term prevention data affect routine use.
Approved weight-management medicines—including GLP-1–based treatment for eligible patients—can produce clinically meaningful weight loss and improve insulin resistance. They are prescribed for obesity treatment according to BMI, complications, contraindications, access, and patient preference—not simply to lower insulin levels.
Once diabetes is diagnosed, medicine selection is based on HbA1c, symptoms, heart disease, heart failure, kidney disease, weight goals, fatty liver disease, hypoglycemia risk, cost, and other factors. Metformin is one option, but it is no longer the only possible initial priority.
Metformin may be used for metabolic features, menstrual irregularity, or fertility-related indications in selected patients. Oral contraceptives, anti-androgen treatment, and fertility therapy address different goals.
Some guidelines allow consideration of pioglitazone in carefully selected people because trials have shown vascular benefit. Weight gain, edema, heart-failure risk, fractures, and other adverse effects require specialist risk-benefit review.
No supplement is proven to match the DPP lifestyle intervention or metformin for preventing type 2 diabetes. Cinnamon, berberine, bitter melon, chromium, and other products may interact with medicine or affect the liver, kidneys, or glucose unpredictably.
Read Natural Diabetes Remedies: What Actually Helps.
Do not judge progress from fasting insulin alone. Useful outcomes may include:
ADA recommends regular monitoring for progression from prediabetes. The interval is commonly at least yearly, but it may be sooner when glucose is near the diabetes threshold, symptoms appear, pregnancy is planned, weight changes rapidly, or a glucose-raising medicine begins.
Routine daily meter testing is not required for every person with insulin resistance or prediabetes. It may be useful when:
A normal meter value does not prove that insulin resistance is gone. A1C and laboratory testing provide different information.
| Area | Question to review |
|---|---|
| Movement | Am I moving most days and strengthening muscles at least twice weekly? |
| Food | Have sugary drinks, refined snacks, or oversized carbohydrate portions decreased? |
| Weight or waist | Is the trend improving when weight loss is an appropriate goal? |
| Sleep | Am I sleeping consistently, and has possible sleep apnea been assessed? |
| Laboratory pattern | Are glucose, HbA1c, triglycerides, or liver markers improving? |
| Treatment barriers | Do cost, pain, stress, food access, work schedule, side effects, or mental health require a different plan? |
Do not prescribe weight loss automatically. Review family history, waist distribution, lipids, sleep, PCOS, medicines, liver disease, lipodystrophy, and other endocrine or genetic conditions. Strength training, aerobic activity, food quality, and cardiovascular-risk treatment remain useful.
PCOS treatment depends on the patient’s priorities: cycle regulation, fertility, excess hair growth, acne, metabolic risk, or weight. Insulin resistance is common but not required for diagnosis.
Pregnancy has separate glucose thresholds and weight goals. Metformin has not consistently prevented gestational diabetes in high-risk people with obesity, PCOS, or preexisting insulin resistance. Do not begin fasting, weight-loss drugs, or supplements during pregnancy.
A history of gestational diabetes increases future type 2 diabetes risk and is one reason metformin may be considered after pregnancy in high-risk prediabetes. Postpartum and lifelong glucose testing remain necessary.
Growth, puberty, family eating patterns, sleep, mental health, weight stigma, and possible type 2 diabetes require pediatric care. Adult calorie targets, fasting plans, and weight-loss medicines should not be copied for children.
Preserving muscle, balance, nutrition, and independence may be more important than aggressive weight loss. Resistance training and adequate protein may need emphasis, with adjustments for kidney function and fall risk.
Protein, potassium, fluid, medicine, and weight-loss recommendations may need modification. Severe liver disease or advanced kidney disease also changes which medicines are safe.
Rigid carbohydrate rules, fasting, frequent weighing, and intensive tracking can worsen symptoms. Use an eating-disorder-informed diabetes team.
Insulin resistance itself is usually not an emergency, but progression to diabetes can cause serious symptoms.
| Myth | More accurate explanation |
|---|---|
| “Avoiding carbohydrates means the body no longer needs insulin.” | The liver makes glucose during fasting, and insulin also regulates fat, protein, and ketone metabolism. |
| “Everyone with high fasting insulin needs metformin.” | Treatment depends on glucose status, overall risk, medical conditions, and whether the result is reliable and clinically meaningful. |
| “Metformin is the only acceptable medicine.” | It has the strongest prevention evidence, but obesity, type 2 diabetes, PCOS, fatty liver, and cardiovascular risk may require other treatments. |
| “Natural alternatives are safer.” | Supplements can interact with medicines and are not proven substitutes for structured lifestyle treatment or metformin. |
| “Insulin resistance always causes symptoms.” | It often develops silently and is detected through risk assessment and laboratory testing. |
| “Normal glucose means insulin resistance has been cured.” | The pancreas may be compensating with high insulin. Long-term risk and associated conditions still need review. |
| “Thirty minutes of walking is enough for everyone.” | Walking is valuable, but the plan should also consider resistance exercise, sedentary time, ability, safety, and progression. |
It can often improve substantially, especially with regular activity, weight loss when appropriate, better sleep, and treatment of contributing conditions. “Reversed” should not be interpreted as permanent immunity from future prediabetes or diabetes.
Muscle insulin sensitivity can improve after individual exercise sessions. Glucose, weight, liver fat, and HbA1c change over days to months. Sustainable trends matter more than a rapid short-term result.
No. It is considered mainly when prediabetes risk is high, type 2 diabetes is present, or another indication such as selected PCOS treatment exists.
A combination of aerobic activity and resistance training is practical for many adults. The best plan is safe, progressive, and sustainable for your health and mobility.
No. Weight loss is useful when overweight or obesity contributes to risk, but lean people can also have insulin resistance. Treatment should not promote underweight, malnutrition, or muscle loss.
No. Prioritize food quality and portions. GI is one tool and does not account for the amount eaten or the complete meal.
It may help selected adults reduce intake or weight, but it is not required and can be unsafe with pregnancy, eating disorders, frailty, insulin, or medicines that cause low glucose.
No. Insulin resistance is central to type 2 diabetes, but type 1 diabetes is autoimmune and requires insulin. Lowering insulin is not an appropriate prevention goal for every diabetes type.
Only when the clinician believes it will change management. Fasting insulin varies by assay and has no universal target. Glucose, HbA1c, and overall risk are usually more actionable.
Medical disclaimer: This page provides general education and does not diagnose insulin resistance, prescribe weight loss, select metformin, or replace medical care. Do not stop medicine, begin fasting, use a supplement, or make a large carbohydrate reduction without professional guidance when you are pregnant, use insulin or hypoglycemia-causing medicine, or have kidney, liver, cardiovascular, endocrine, or eating-disorder concerns.